David A. Metcalfe - Dec 27, 2022 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC. (NXGN)

Role
Chief Technology Officer
Signature
/s/ Jeffrey D. Linton, Attorney-in-Fact for David A. Metcalfe
Stock symbol
NXGN
Transactions as of
Dec 27, 2022
Transactions value $
-$477,294
Form type
4
Date filed
12/28/2022, 03:14 PM
Previous filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXGN Common Stock Options Exercise +42.2K +26.19% 203K Dec 27, 2022 Direct F1
transaction NXGN Common Stock Tax liability -$397K -20.9K -10.29% $18.95 182K Dec 27, 2022 Direct F2
transaction NXGN Common Stock Tax liability -$80.7K -4.26K -2.33% $18.95 178K Dec 27, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXGN Performance Stock Units Options Exercise $0 -42.2K -100% $0.00* 0 Dec 27, 2022 Common Stock 42.2K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested.
F2 Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units.
F3 Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock.
F4 On December 27, 2022, 42,215 performance stock units vested for the reporting person based on the Company's achievement of fiscal year 2021 and 2022 revenue goals and modified for 3-year total shareholder return ("TSR") performance for the period December 26, 2019 through December 27, 2022.